Mother‐to‐child transmission of hepatitis B virus after amniocentesis: A retrospective matched cohort study
- 27 March 2019
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 39 (6) , 431-440
Abstract
Objective: The objective of this study is to determine whether amniocentesis increases the risk of mother‐to‐child transmission (MTCT) of hepatitis B virus (HBV) and evaluate risk factors for MTCT.Methods: One hundred forty‐three hepatitis B surface antigen (HBsAg)–positive women with amniocentesis were enrolled into the amniocentesis group. Six hundred five nonamniocentesis cases were matched with amniocentesis cases based on maternal viral loads, antiviral therapy regimens, and delivery dates. MTCT of HBV was defined as HBsAg and/or DNA positivity in infants from birth to age 7 to 12 months.Results: Mother‐to‐child transmission rate was significantly higher in HBsAg‐positive women with amniocentesis than in those without amniocentesis (2.80% vs 0.50%; relative risk [RR], 5.64; 95% CI, 1.28‐24.93). In the amniocentesis group, maternal HBV DNA more than or equal to 7.0 log10 IU/mL and hepatitis B e‐antigen (HBeAg) positivity were associated with higher MTCT rates than maternal HBV DNA less than 7.0 log10 IU/mL (10.81% vs 0%, p = .004) and HBeAg negativity (8.16% vs 0%, p = .013), and antiviral therapy reduced MTCT rate from 14.3% to 0% (p = .554) when maternal HBV DNA was more than or equal to 7.0 log10 IU/mL.Conclusions: Amniocentesis increases the risk of MTCT in women with hepatitis B, and maternal HBV DNA more than or equal to 7.0 log10 IU/mL and HBeAg positivity are risk factors for MTCT. Antiviral therapy may be effective to prevent MTCT after amniocentesis in highly viremic mothers.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2014A030313043)
This publication has 35 references indexed in Scilit:
- Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for interventionJournal of Hepatology, 2013
- Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virusJournal of Infection, 2013
- An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B VirusClinical Gastroenterology and Hepatology, 2012
- A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infectionJournal of Hepatology, 2011
- Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothersJournal of Viral Hepatitis, 2011
- Chronic Viral Infections and Invasive Procedures: Risk of Vertical Transmission and Current RecommendationsFetal Diagnosis and Therapy, 2010
- Epidemiology and Prevention of Hepatitis B Virus InfectionInternational Journal of Medical Sciences, 2005
- Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriersInfectious Diseases in Obstetrics and Gynecology, 1999
- Early invasive prenatal diagnosis in HBsAg‐positive womenPrenatal Diagnosis, 1994
- Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infectionArchives of Gynecology and Obstetrics, 1994